Meclizine Hydrochloride NDC 42806-014

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-014Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0014Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42806-014-01	42806001401	100 TABLET in 1 BOTTLE (42806-014-01)Marketed from Apr 30, 2012
42806-014-10	42806001410	1000 TABLET in 1 BOTTLE (42806-014-10)Marketed from Apr 30, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meclizine Hydrochloride
Generic name (nonproprietary): meclizine hydrochloride
Active ingredients: Meclizine hydrochloride — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Epic Pharma LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200294
Marketing start: Apr 30, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Emesis Suppression (Physiologic effect)
Identifiers: Product ID 42806-014_42600718-075b-481b-8fec-cb6cbadab7deSPL ID 42600718-075b-481b-8fec-cb6cbadab7deSPL set ID 467e464b-bbaf-4053-9136-39e47a92fa05RxCUI 995624, 995666UNII HDP7W44CIO
Pharmacologic class: Antiemetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806001401 followed by a unit qualifier and the quantity

Package 42806-0014-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2020.

Indications (excerpt from the label)

Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200294

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200294
Product	Strength	Form · route	Labeler	Product NDC
Meclizine Hydrochloride	Meclizine hydrochloride 25 mg/1	TabletOral	Proficient Rx LP	63187-258
Meclizine Hydrochloride	Meclizine hydrochloride 12.5 mg/1	TabletOral	Epic Pharma LLC	42806-012